GABRIELA NORTH: Open Payments
NPI 1235743725 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,060 in 119 payments from 15 companies in 2025. Trend: 2023 $4,373 · 2024 $5,772 · 2025 $4,060
Food & beverage: $4,060
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 23 | $1,056 |
| UCB, Inc. | 42 | $1,023 |
| Neurelis, Inc. | 9 | $397 |
| SK Life Science, Inc. | 7 | $396 |
| CATALYST PHARMACEUTICALS, INC. | 11 | $286 |
| LivaNova USA, Inc. | 4 | $261 |
| Otter Pharmaceuticals, LLC | 5 | $151 |
| SpringWorks Therapeutics, Inc. | 2 | $147 |
| Aucta Pharmaceuticals, Inc. | 6 | $131 |
| ACADIA Pharmaceuticals Inc | 4 | $93 |
Products named: EPIDIOLEX, Fintepla, VALTOCO, Nayzilam, FYCOMPA, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, XCOPRI, Briviact.
Industry payments across IN — which companies pay providers there.
